Greenway Medical (GWAY) 10-Q 12 Nov 13 2014 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Sep. 30, 2013	Nov. 11, 2013
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'GREENWAY MEDICAL TECHNOLOGIES INC	'
Entity Central Index Key	'0001080747	'
Trading Symbol	'gway	'
Current Fiscal Year End Date	'--06-30	'
Entity Filer Category	'Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	1,000
Document Type	'10-Q	'
Document Period End Date	30-Sep-13	'
Amendment Flag	'false	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q1	'

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (Unaudited) (USD $)	Sep. 30, 2013	Jun. 30, 2013
In Thousands, unless otherwise specified
Current assets:	'	'
Cash and cash equivalents	$6,192	$3,184
Short-term investments	1,306	8,043
Accounts receivable, net of $980 and $900 in allowance for doubtful accounts	22,007	21,151
Prepaids and other current assets	4,412	4,056
Deferred tax assets	2,557	2,407
Total current assets	36,474	38,841
Property and equipment, net	27,839	28,416
Software development cost, net	31,505	28,142
Acquired intangibles, net	1,734	1,819
Deferred tax assets - noncurrent	28,549	26,903
Goodwill	1,540	1,540
Other assets	467	468
Total assets	128,108	126,129
Current liabilities:	'	'
Accounts payable	14,581	9,325
Accrued liabilities	6,782	5,846
Deferred revenue	8,583	9,323
Total current liabilities	29,946	24,494
Commitments and contingencies	'	'
Shareholders' equity:	'	'
Common stock	3	3
Additional paid-in capital	246,756	245,412
Accumulated deficit	-148,597	-143,780
Total shareholders' equity	98,162	101,635
Total liabilities and shareholders' equity	$128,108	$126,129

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) (USD $)	Sep. 30, 2013	Jun. 30, 2013
In Thousands, unless otherwise specified
Statement Of Financial Position [Abstract]	'	'
Allowance for doubtful accounts	$980	$900

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012
Revenue:	'	'
System sales	$8,512	$9,035
Training and consulting services	3,984	6,863
Support services	12,263	10,292
Electronic data interchange and business services	8,871	6,584
Total revenue	33,630	32,774
Cost of revenue:	'	'
System sales	6,156	3,007
Training and consulting services	3,564	4,602
Support services	3,423	3,125
Electronic data interchange and business services	5,832	4,194
Total cost of revenue	18,975	14,928
Gross profit	14,655	17,846
Operating expenses:	'	'
Sales, general and administrative	16,729	13,324
Research and development	4,535	4,772
Total operating expenses	21,264	18,096
Loss from operations	-6,609	-250
Interest income, net	18	289
Other expense, net	-19	-24
(Loss) income before provision for income taxes	-6,610	15
(Benefit) provision for income taxes	-1,793	7
Net (loss) income	($4,817)	$8
Net (loss) income per share:	'	'
Basic (in dollars per share)	($0.16)	'
Diluted (in dollars per share)	($0.16)	'
Weighted average number of common shares outstanding	'	'
Basic (in shares)	29,800	29,295
Diluted (in shares)	29,800	30,603

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities:	'	'
Net (loss) income	($4,817)	$8
Adjustments to reconcile net (loss) income to net cash provided by operating activities:	'	'
Stock-based compensation expense	1,060	1,099
Deferred income tax benefit	-1,796	'
Depreciation and amortization	2,952	1,784
Provision for bad debts	293	345
Changes in current assets and liabilities:	'	'
Accounts receivable	-1,150	4,248
Prepaids and other assets	-355	-639
Accounts payable and accrued liabilities	6,192	-3,940
Deferred revenue	-740	-542
Net cash provided by operating activities	1,639	2,363
Cash flows from investing activities:	'	'
Sale (purchase) of short-term investments, net	6,737	-306
Purchases of property and equipment	-843	-1,252
Capitalized software development costs	-4,810	-2,856
Net cash provided by (used in) investing activities	1,084	-4,414
Cash flows from financing activities:	'	'
Payments on obligation for acquired technology	'	-23
Proceeds from exercise of stock options and warrants	285	1,464
Net cash provided by financing activities	285	1,441
Net increase (decrease) in cash and cash equivalents	3,008	-610
Cash and cash equivalents at beginning of period	3,184	5,585
Cash and cash equivalents at end of period	6,192	4,975
Supplemental cash flow information:	'	'
Cash paid for interest	7	5
Cash paid for taxes	$55	$7

Basis_of_Presentation_and_Desc

Basis of Presentation and Description of Company	3 Months Ended
	Sep. 30, 2013
Basis Of Presentation and Description Of Company [Abstract]	'
Basis of Presentation and Description of Company	'
	Note 1.  Basis of Presentation and Description of Company
	We prepared the accompanying interim condensed and consolidated financial statements in accordance with the instructions for Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements. We believe these condensed consolidated financial statements reflect all adjustments (consisting of only normal recurring accruals) considered necessary for a fair presentation. Operating results for the three months ended September 30, 2013, are not necessarily indicative of the results that may be expected for our fiscal year ending June 30, 2014. For more information regarding our results of operations and financial position, refer to the consolidated financial statements and footnotes included in our Form 10-K for our fiscal year ended June 30, 2013, on file with the Securities and Exchange Commission (“SEC”).
	As appropriate to the context, “Greenway”, the “Company”, “we”, “us” and “our” are used interchangeably to refer to Greenway Medical Technologies, Inc. and its subsidiary, originally incorporated in Georgia in 1998. We develop, market and sell an integrated suite of healthcare technology solutions, including practice management and electronic medical record software applications, and related technologies and services for physician practices, clinics and other providers in ambulatory settings throughout the United States.  The Company is subject to the risks and challenges similar to other companies in the health care information technology market including, but not limited to, operating in a rapidly evolving market, competition from larger companies, dependence on new products and on key personnel, as well as the regulatory requirements in the healthcare information environment.
	Greenway Medical Technologies, Inc. acquired the assets of GHN-Online, Inc. (“GHN”) (See Note 5) effective December 31, 2012 and, in conjunction with the acquisition, formed Greenway, LLC, a wholly-owned subsidiary. The acquisition was accounted for as a purchase business combination. The results of GHN’s operations are included in the Company’s consolidated financial statements for the periods subsequent to the effective date of the acquisition. All intercompany transactions have been eliminated in the accompanying consolidated financial statements.

Accounting_Policies

Accounting Policies	3 Months Ended
	Sep. 30, 2013
Accounting Policies [Abstract]	'
Accounting Policies	'
	Note 2.  Accounting Policies
	Our accounting policies are consistent with those described in our Significant Accounting Policies for our fiscal year ended June 30, 2013, in our Form 10-K filed with the SEC.
	Concentration of credit risk
	Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash, cash equivalents and trade accounts receivable.  The Company maintains cash and cash equivalents with various financial institutions. The Company performs periodic evaluations of the relative credit standing of those financial institutions that are considered in the Company’s investment strategy. Trade receivables are unsecured and the Company is at risk to the extent such amounts become uncollectible.
	For the three months ended September 30, 2013, the Company had one customer that accounted for 17% of consolidated revenue and the same customer accounted for 15% of total accounts receivable at each of September 30, 2013 and June 30, 2013.

ShortTerm_Investments

Short-Term Investments	3 Months Ended
	Sep. 30, 2013
Schedule Of Investments [Abstract]	'
Short-Term Investments	'
	Note 3. Short-Term Investments
	Short-term investments consist of mutual funds, money market funds and U.S. agency and corporate bonds with original maturities greater than three months and remaining maturities of less than one year. Investments are also made in corporate bonds with original maturities of greater than one year but maximum remaining maturities of 18 months; these investments are also included in short-term investments since the Company’s intent is to convert them into cash as may be necessary to meet liquidity needs. At September 30, 2013, all of the Company’s investments were classified as available-for-sale and are reported at fair value with any changes in market value reported as a part of comprehensive income. As of September 30, 2013, gross accumulated unrealized gains and losses for these investments were not material. Fair value is based on the Level 1 or 2 criteria of the fair value hierarchy specified in ASC 820-10, Fair Value Measurements and Disclosures.
	The Company applies ASC 820, Fair Value Measurements and Disclosures, with respect to fair value of (a) nonfinancial assets and liabilities that are recognized or disclosed at fair value in the Company’s consolidated financial statements on a recurring basis and (b) all financial assets and liabilities. ASC 820 prioritizes the inputs used in measuring fair value as follows: Level 1 — Quoted market prices in active markets for identical assets or liabilities; Level 2 — Observable inputs other than those included in Level 1 (for example, quoted market prices for similar assets in active markets or quoted market prices for identical assets in inactive markets); and Level 3 — Unobservable inputs reflecting management’s own assumptions about the inputs used in estimating the value of the asset.  The Company’s financial instruments consist primarily of short term investments, which are measured using Level 1 inputs. All of the investments were identified as Level 1 at September 30, 2013 and June 30, 2013.  The Company did not identify any transfers among levels of the fair value measurements hierarchy during the three month period ended September 30, 2013 or the fiscal year ended June 30, 2013.
	Short-Term Investments (available-for-sale-securities) consist of the following (in thousands):
		September 30,		June 30,
		2013		2013
	Mutual funds	$	1,024	$	7,946
	Corporate bonds		84		84
	Money market funds		198		13
	Total	$	1,306	$	8,043

Property_and_Equipment

Property and Equipment	3 Months Ended
	Sep. 30, 2013
Property, Plant and Equipment [Abstract]	'
Property and Equipment	'
	Note 4. Property and Equipment
	Property and equipment consist of the following (in thousands):
		Estimated
		useful lives	30-Sep-13			30-Jun-13
		(in years)
	Land	—	$	1,287		$	1,287
	Building and related	15 to 39		18,053			18,053
	Acquired technology	3		7,581			7,581
	Purchased software	3		6,124			5,874
	Furniture and fixtures	5		1,656			1,582
	Equipment	3		5,281			4,876
				39,982			39,253
	Less - Accumulated depreciation and amortization			(12,529	)		(11,109	)
				27,453			28,144
	Construction in progress			386			272
	Total		$	27,839		$	28,416
	Construction of New Facilities and Real Estate Tax Incentive Transaction
	In December 2011, we entered into a sale-leaseback transaction pursuant to which we sold certain land and a building under development as our new administrative headquarters located in Carrollton, Georgia. The transaction contemplates an ultimate total purchase price of approximately $12 million. This agreement is intended to permit counties to attract business investment by offering property tax incentives. In accordance with Georgia law, we entered into this sale-leaseback agreement with the Carroll County Payroll Development Authority (the “County”) and acquired an industrial revenue bond. The arrangement is structured so that our lease payments to the County equal and offset the County’s bond payments to the Company. The Bond is non-recourse to the County, our lease payments are pledged to secure repayment of the Bond, and the lease and bond provide for the legal right of offset. Consequently, the investment and lease obligation related to this arrangement have been offset in our balance sheet. The agreement has an expiration date of 2021. If we had not entered into this transaction, property tax payments would have been higher. We can reacquire such property and terminate the agreement at a nominal price of ten dollars. The subject property was included in property and equipment at September 30, 2013 and June 30, 2013, in the accompanying consolidated balance sheets.
	Software Development Costs
	We apply the provisions of ASC 985-20, Software, Costs of Computer Software to be Sold, Leased or Marketed, which requires the capitalization of costs incurred in connection with the research and development of new software products and enhancements once technological feasibility is established. Such costs are amortized on a straight-line basis over the estimated economic life of the related product, which is typically three years. The establishment of technological feasibility and the ongoing assessment of the recoverability of these costs require considerable judgment by management with respect to certain external factors including, but not limited to, anticipated future gross product revenue, estimated economic life, and changes in technology. Capitalized software development costs were $4,810,000 and $2,856,000 for the three months ended September 30, 2013 and 2012, respectively. Amortization of capitalized software development costs was $1,447,000 and $1,000,000 for the three months ended September 30, 2013 and 2012, respectively, and is recorded in cost of system sales.

Acquisition

Acquisition	3 Months Ended
	Sep. 30, 2013
Business Combinations [Abstract]	'
Acquisition	'
	Note 5.  Acquisition
	The Company has accounted for all business combinations using the purchase method to record a new cost basis for the assets acquired and liabilities assumed. The Company allocated the purchase price to intangible assets representing developed technology, customer relationships, trademarks, and non-competition agreements. The excess of purchase price over the estimated fair value of the tangible assets acquired and liabilities assumed and the separately recognized intangible assets has been recorded as goodwill in the accompanying consolidated financial statements. The goodwill is attributable to synergies achieved through the streamlining of operations combined with improved margins attainable from increased market presence. None of the acquisitions have a material impact on the Company’s operations. The carrying value of goodwill is evaluated annually for potential impairment or whenever changes in circumstances may indicate that impairment has occurred. The goodwill is deductible for tax purposes.
	On December 31, 2012, we acquired certain assets of GHN in exchange for cash consideration totaling $5.5 million. Additionally, the Company incurred transaction costs totaling approximately $145,000; GHN provides clearinghouse and revenue cycle services to healthcare providers and we believe the technology acquired will enable us to offer better solutions to connect our customers with their payers for the purposes of improving their revenue cycle management processes and outcomes. Based on estimated fair value of the working capital, property and equipment and identifiable intangibles, the consideration of $5.5 million was allocated to the assets acquired  in the following amounts:
	Assets Acquired	Estimated		Estimated Useful
		Fair Value		Life (in years)
		(in thousands)
	Net Working Capital	$	69	Not Applicable
	Property and Equipment		352	3
	Developed Technology		2,437	3
	Customer Relationships		1,054	9
	Non-competition Agreements		211	5-Mar
	Trademarks		277	10
	Goodwill		1,100	Indefinite
	Total fair value of consideration	$	5,500

Transactions_with_Related_Part

Transactions with Related Parties	3 Months Ended
	Sep. 30, 2013
Related Party Transactions [Abstract]	'
Transactions with Related Parties	'
	Note 6.  Transactions with Related Parties
	Effective July 1, 2000, the Company entered into an agreement to lease the corporate office from Green Family Real Estate, LLC, an entity controlled by the Company’s Chairman, for approximately $20,000 per month, plus annual adjustments for inflation, until June 30, 2015 (see Note 11).  In 2000, the Company entered into an agreement to rent an airplane from Greenway Air, LLC, an entity controlled by the Company’s Chairman. The Company pays according to usage of the airplane.  Expenses incurred related to this agreement were approximately $0 and $18,000 for the three months ended September 30, 2013 and 2012, respectively. In March 2002, the Company purchased a 1% interest in Greenway Air, LLC, for $12,500 and in September 2012 paid $427,000 to purchase an additional 15.75% interest. This investment is recorded at cost in the caption “Other Assets” in the accompanying consolidated balance sheets. The Company has considered the applicable guidance regarding variable interest entities.  The Company has  determined that these arrangements do not meet the definition of variable interest entities.
	The Company has two institutional shareholders who, as of September 30, 2013 and June 30, 2013, collectively owned approximately 44% (25% for one investor and 19% for the other) of the Company’s common shares outstanding. One representative of each of these institutional shareholders sits on the Company’s Board of Directors. Given this substantial ownership position, these shareholders are able individually, and collectively, to exercise substantial influence over the affairs of the Company.

Credit_Facility

Credit Facility	3 Months Ended
	Sep. 30, 2013
Debt Disclosure [Abstract]	'
Credit Facility	'
	Note 7.  Credit Facility
	In March 2011, the Company closed on a loan agreement which provides financing up to $5 million based on eligible receivables.  The loan agreement carries interest at LIBOR plus 275 basis points, and is secured by a pledge of the Company’s assets.  The loan agreement contains customary covenants and other provisions that prohibit payment of cash dividends. There were no amounts outstanding on the credit facility at September 30, 2013 and June 30, 2013. The Company had a letter of credit in the amount of $500,000 that reduced the availability of the loan at September 30, 2013 and June 30, 2013. Therefore, there was $4.5 million available on the facility at September 30, 2013 and June 30, 2013. On August 16, 2013, the Company executed a non-binding commitment with its lender for a $25 million, four-year facility. The commitment is subject to certain conditions. The non-binding commitment would replace the $5 million loan and has substantially the same terms and conditions.   Instead of entering into such proposed $25 million credit facility, the maturity of the $5 million credit facility was extended to November 15, 2013. As a result of the Transaction (See Note 13), the Company’s $5 million credit facility was paid-off in full and canceled.

Shareholders_Equity

Shareholders' Equity	3 Months Ended
	Sep. 30, 2013
Stockholders' Equity Note [Abstract]	'
Shareholders' Equity	'
	Note 8.  Shareholders’ Equity
	Stock Options
	On December 16, 2011, we received shareholder approval of the Greenway Medical Technologies, Inc. 2011 Stock Plan (the “2011 Plan”) that provides for issuance of equity awards of up to 3.0 million shares of our common stock. For the three months ended September 30, 2013 and 2012, respectively, options for 34,250 and 884,900 shares of our common stock were granted under the 2011 Plan. We also have options granted, fully-vested and outstanding under our 1999 and 2004 Stock Plan. At September 30, 2013 and 2012, approximately 3.7 million and 4.0 million options, respectively, were outstanding under the various stock compensation plans.  We expense stock compensation costs over the vesting periods of each grant. For each of the three months ended September 30, 2013 and 2012 we expensed approximately $1.1 million (in each of the three month periods) in connection with outstanding option awards. As of September 30, 2013, there was $9.5 million of total unrecognized compensation cost related to option awards granted under the various Plans. This cost is expected to be recognized over a period of 2.0 years. A reconciliation of stock option expense from the consolidated statements of operations is as follows (in thousands):
		Three Months Ended September 30,
		2013			2012
	Cost of revenue:
	System sales	$	8		$	8
	Training and consulting services		51			47
	Software support services		26			26
	Electronic data interchange and business services		5			5
	Total cost of revenue		90			86
	Operating expenses:
	Sales, general and administrative		800			843
	Research and development		170			170
	Total operating expenses		970			1,013
	Total stock-compensation expense	$	1,060		$	1,099
	The assumptions utilized for stock option grants were as follows:
		Three months ended September 30,
		2013
					2012
	Risk-free interest rate		1.78	%		.68% - .72	%
	Expected dividend yield		—			—
	Expected volatility		55.9	%		57.7	%
	Expected lives of options	6.25 years			6.25 years
	Forfeiture rate		1	%		1	%
	Fair Value		$8.75			$8.24 - $8.62

Income_Taxes

Income Taxes	3 Months Ended
	Sep. 30, 2013
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	Note 9.  Income Taxes
	As of September 30, 2013, the Company had gross net operating losses (NOLs) of approximately $74 million. These NOLs will be available to offset any future taxable income and will begin to expire in 2021. The Company has also generated research credit carryforwards of approximately $4.8 million.  As of September 30, 2013 and June 30, 2013, Management determined that it was more likely than not that all net deferred tax assets, except for specific state R&D income tax carryforwards, would be fully realized based upon future projections of taxable income. Consequently, the Company recorded a valuation allowance of $784,000 specifically attributable to the state R&D tax carryforwards that may not be fully utilized before the Company’s income allocated to those states use up the existing net operating losses.
	The tax provision for the periods ended September 30, 2013 and 2012 reflect an effective tax rate of 27% and 46%, respectively.  Permanent differences, primarily stock-based compensation and income tax credits impact the operating loss of $6,610,000 for the three months ended September 30, 2013 more than the income before income tax of $15,000 for the three months ended September 30, 2012.   Stock-based compensation expenses of $1,060,000 are recorded currently as a deduction to the consolidated statement of operations but are not available for tax deduction because the Company is in a net operating loss position.  This is a significant driver of the lower tax rate for the three months ended September 30, 2013.
	As of September 30, 2013 and June 30, 2013, the Company had no unrecognized tax benefits.  Net operating loss and R&D credit carryforwards remain subject to examination to the extent they are carried forward and impact a year that is open to examination by tax authorities.

Net_Income_Loss_Per_Share

Net Income (Loss) Per Share	3 Months Ended
	Sep. 30, 2013
Earnings Per Share [Abstract]	'
Net Income (Loss) Per Share	'
	Note 10.  Net Income (Loss) Per Share
	Basic income (loss) per share is computed by dividing net income (loss) by the sum of the weighted average number of common shares outstanding during the period.   Diluted per share amounts give effect to all potentially dilutive common share equivalents outstanding during the period. Such potentially dilutive common share equivalents include stock options exercisable for shares of common stock totaling approximately 1.0 and 1.3 million shares for the three months ended September 30, 2013 and 2012, respectively.  The dilutive effect of outstanding stock options is computed using the treasury stock method. The computation of diluted loss per share does not assume conversion, exercise, or contingent exercise of securities that would have an anti-dilutive effect on earnings and inasmuch as inclusion of any or all of the potentially dilutive common share equivalents is anti-dilutive for the three months ended September 30, 2013, presentation of loss per share — basic and diluted are the same for the periods presented. There were no such anti-dilutive securities that were excluded from the calculation of common shares outstanding as of September 30, 2012, however, the net income per share, did not result in a basic or fully dilutive per share amount as it was not significant for presentation (the gross dollar amounts of earnings per share were not sufficiently significant to derive a meaningful per share calculation).

Commitments_and_Contingencies

Commitments and Contingencies	3 Months Ended
	Sep. 30, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	Note 11.  Commitments and Contingencies
	We are engaged from time to time in certain legal disputes arising in the ordinary course of business, including employment claims, and challenges to our intellectual property.  We believe we have adequate legal defenses and that the likelihood of a loss contingency relating to the ultimate disposition of any of these disputes is remote.  When the likelihood of a loss contingency becomes at least reasonably possible, we will revise our disclosures in accordance with the relevant authoritative guidance.  In addition, we will accrue a liability for loss contingencies when we believe that it is both probable that a liability has been incurred and that we can reasonably estimate the amount of the loss.   There were no filed claims pending against the Company at September 30, 2013. There are, however, asserted unfilled claims that, given the early stage of these legal matters and the nature of the claims, it is not possible to estimate a loss or range of loss for the ongoing claim. Management does not feel that any individual claim is material to disclose. We will continue to evaluate the potential exposure related to these matters in future periods.
	As discussed in Note 6, the Company leases office space from related parties under operating leases through 2015.   Rental expense for all building and equipment leases totaled approximately $575,000 and $407,000 for the three months ended September 30, 2013 and 2012, respectively.

Segment_Information

Segment Information	3 Months Ended
	Sep. 30, 2013
Segment Reporting [Abstract]	'
Segment Information	'
	Note 12.  Segment Information
	The Company complies with ASC Topic 280, Segment Reporting. ASC 280, which is based on a management approach to segment reporting and requires the Company to disclose information about the business components (operating segments) as utilized to make operating decisions and assess performance. The objective of this guidance is to help financial statement users understand the Company’s performance, assess prospects for future cash flows and judge the entity as a whole. An operating segment is defined as a component that engages in business activities whose operating results are reviewed by the chief operating decision maker and for which discrete financial information is available. The Company manages its resources and assesses its performance on an enterprise-wide basis. The Company does report revenue according to the nature of the products and services provided to its customers; providers in various settings within the ambulatory sector of the domestic healthcare market who share similar economic characteristics.

Subsequent_Event

Subsequent Event	3 Months Ended
	Sep. 30, 2013
Subsequent Events [Abstract]	'
Subsequent Event	'
	Note 13.  Subsequent Event
	The Company was acquired by VCG Holdings, LLC, a wholly-owned indirect subsidiary of Vista Equity Partners Fund IV, L.P. (“Vista”), on November 4, 2013 (the “Transaction”).  Vista commenced a tender offer for any and all of the Company’s outstanding shares at $20.35 per share with the Securities and Exchange Commission (the “SEC”) on October 4, 2013.  The Company’s board of directors and stockholders approved of the terms of the tender offer and recommended to the Company’s stockholders that they tender their shares into the offer. The tender offer expired on November 1, 2013, and the acquisition was completed on the next business day, November 4, 2013.  On November 5, 2013, the New York Stock Exchange filed with the SEC a Form 25, Notification of Removal from Listing and/or Registration under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), to delist and deregister the Company’s shares.  Upon effectiveness of such Form 25, the Company intends to file with the SEC a Certification on Form 15 under the Exchange Act to suspend the Company’s remaining reporting obligations under the Exchange Act. The results of operations and cash flows from the Company subsequent to the completion of the merger and the closing of the Transaction on November 4, 2013 will no longer be public.
	The Company recorded approximately $1.8 million of expenses related to the Transaction at September 30, 2013 in the accompanying consolidated statements of operations under the caption “Sales, general and administrative” expenses. These cost were incurred by the Company at September 30, 2013 and related to the pending Transaction.
	On or about October 7, 2013, a putative class action lawsuit (Booth Family Trust IRA v. Greenway Medical Technologies, Inc. et al., Case No.: 13-A-08600-2) was filed in the Superior Court of the State of Georgia, County of Gwinnett, against the Company and each member of the Company’s board of directors (the “Booth Family Trust Action”). The Complaint asserts that the Company’s directors breached their fiduciary duties to the Company’s public stockholders by, among other things, (i) agreeing to sell the Company at an unfair price, (ii) implementing preclusive deal protection deterring competing, superior bids, and (iii) entering individual tender and support agreements. The Complaint sought injunctive relief, rescission, and, among other remedies, an award of costs and expenses, including a reasonable allowance for attorneys’ and experts’ fees.
	On or about October 9, 2013, the Complaint in the Booth Family Trust Action was amended to include allegations, among others, that (i) the proposed transaction is financially unfair to the Company’s stockholders, (ii) the process undertaken by the Company when entering into the Merger Agreement with Vista’s affiliates was inadequate and flawed, and (iii) the Schedule 14D-9 failed to disclose all material facts and/or provided misleading information regarding the proposed transaction to the Company’s stockholders.
	On October 25, 2013, solely to avoid the costs, risks and uncertainties inherent in litigation, and without admitting any liability or wrongdoing, the parties to the stockholder putative class action lawsuit pending in the Superior Court of the State of Georgia, County of Gwinnett, captioned Booth Family Trust IRA v. Greenway Medical Technologies, Inc. et al., Case No.: 13-A-08600-2, entered into a memorandum of understanding (the “MOU”) setting forth an agreement-in-principle to settle all claims related thereto. In connection with the MOU, the Company agreed to amend the Schedule 14D-9, previously filed with the SEC, to include certain supplemental disclosures. The settlement is subject to, among other items, the execution of a stipulation of settlement and final approval by the Superior Court of the State of Georgia. Subject to satisfaction of the conditions set forth in the MOU, the defendants, Vista and their respective affiliates, among others, will be released by the plaintiff and all members of the putative class of Company stockholders from (i) all claims concerning or arising out of the tender offer for all outstanding shares of the Company, (ii) the Agreement and Plan of Merger, dated as of September 23, 2013, by and among VCG Holdings, LLC, a Delaware limited liability company (“Parent”), Crestview Acquisition Corp., a Delaware corporation and a direct wholly-owned subsidiary of Parent (“Merger Sub”), and the Company, (iii) the merger by which Greenway and Merger Sub merged, with Greenway continuing as the surviving corporation as a direct, wholly–owned subsidiary of Parent, and (iv) the disclosures relating to the foregoing.
	The Booth Family Trust Action settlement and related cost were paid by Vista as a cost of the Transaction. There were no amounts accrued for the Booth Family Trust Action in the accompanying financial statements at September 30, 2013. The Transaction could result in other claims, however, there are no pending lawsuits at the time of filing this Form 10Q.

Accounting_Policies_and_New_Ac

Accounting Policies and New Accounting Standards (Policies)	3 Months Ended
	Sep. 30, 2013
Accounting Policies [Abstract]	'
Concentration of credit risk	'
	Concentration of credit risk
	Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash, cash equivalents and trade accounts receivable.  The Company maintains cash and cash equivalents with various financial institutions. The Company performs periodic evaluations of the relative credit standing of those financial institutions that are considered in the Company’s investment strategy. Trade receivables are unsecured and the Company is at risk to the extent such amounts become uncollectible.
	For the three months ended September 30, 2013, the Company had one customer that accounted for 17% of consolidated revenue and the same customer accounted for 15% of total accounts receivable at each of September 30, 2013 and June 30, 2013.

ShortTerm_Investments_Tables

Short-Term Investments (Tables)	3 Months Ended
	Sep. 30, 2013
Schedule Of Investments [Abstract]	'
Schedule of available-for-sale-securities	'
		September 30,		June 30,
		2013		2013
	Mutual funds	$	1,024	$	7,946
	Corporate bonds		84		84
	Money market funds		198		13
	Total	$	1,306	$	8,043

Property_and_Equipment_Tables

Property and Equipment (Tables)	3 Months Ended
	Sep. 30, 2013
Property, Plant and Equipment [Abstract]	'
Schedule of property and equipment	'
		Estimated
		useful lives	30-Sep-13			30-Jun-13
		(in years)
	Land	—	$	1,287		$	1,287
	Building and related	15 to 39		18,053			18,053
	Acquired technology	3		7,581			7,581
	Purchased software	3		6,124			5,874
	Furniture and fixtures	5		1,656			1,582
	Equipment	3		5,281			4,876
				39,982			39,253
	Less - Accumulated depreciation and amortization			(12,529	)		(11,109	)
				27,453			28,144
	Construction in progress			386			272
	Total		$	27,839		$	28,416

Acquisition_Tables

Acquisition (Tables)	3 Months Ended
	Sep. 30, 2013
Business Combinations [Abstract]	'
Schedule of estimated fair value of the identifiable intangibles	'
	Assets Acquired	Estimated		Estimated Useful
		Fair Value		Life (in years)
		(in thousands)
	Net Working Capital	$	69	Not Applicable
	Property and Equipment		352	3
	Developed Technology		2,437	3
	Customer Relationships		1,054	9
	Non-competition Agreements		211	5-Mar
	Trademarks		277	10
	Goodwill		1,100	Indefinite
	Total fair value of consideration	$	5,500

Shareholders_Equity_Tables

Shareholders' Equity (Tables)	3 Months Ended
	Sep. 30, 2013
Stockholders' Equity Note [Abstract]	'
Schedule of unrecognized compensation cost related to option awards granted under the various plan	'
		Three Months Ended September 30,
		2013			2012
	Cost of revenue:
	System sales	$	8		$	8
	Training and consulting services		51			47
	Software support services		26			26
	Electronic data interchange and business services		5			5
	Total cost of revenue		90			86
	Operating expenses:
	Sales, general and administrative		800			843
	Research and development		170			170
	Total operating expenses		970			1,013
	Total stock-compensation expense	$	1,060		$	1,099
Schedule of assumptions utilized for stock option grants	'
		Three months ended September 30,
		2013
					2012
	Risk-free interest rate		1.78	%		.68% - .72	%
	Expected dividend yield		—			—
	Expected volatility		55.9	%		57.7	%
	Expected lives of options	6.25 years			6.25 years
	Forfeiture rate		1	%		1	%
	Fair Value		$8.75			$8.24 - $8.62

Accounting_Policies_Detail_Tex

Accounting Policies (Detail Textuals ) (Credit concentration risk)	3 Months Ended	12 Months Ended
	Sep. 30, 2013	Jun. 30, 2013
	Customer	Customer
Sales Revenue	'	'
Concentration Risk [Line Items]	'	'
Number of customer	1	'
Concentration risk percentage	17.00%	'
Accounts Receivable	'	'
Concentration Risk [Line Items]	'	'
Number of customer	1	1
Concentration risk percentage	15.00%	15.00%

ShortTerm_Investments_Details

Short-Term Investments (Details) (USD $)	Sep. 30, 2013	Jun. 30, 2013
In Thousands, unless otherwise specified
Schedule of Available-for-sale Securities [Line Items]	'	'
Available-for-sale securities	$1,306	$8,043
Mutual funds	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Available-for-sale securities	1,024	7,946
Corporate bonds	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Available-for-sale securities	84	84
Money market funds	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Available-for-sale securities	$198	$13

Property_and_Equipment_Summary

Property and Equipment - Summary of Property and equipment (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Jun. 30, 2013
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, Gross	$39,982	$39,253
Less - Accumulated depreciation and amortization	-12,529	-11,109
Property, plant and equipment excluding construction in progress	27,453	28,144
Construction in progress	386	272
Total	27,839	28,416
Land	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, Gross	1,287	1,287
Building and related	'	'
Property, Plant and Equipment [Line Items]	'	'
Estimated useful lives	'15 to 39 years	'
Property and equipment, Gross	18,053	18,053
Acquired technology	'	'
Property, Plant and Equipment [Line Items]	'	'
Estimated useful lives	'3 years	'
Property and equipment, Gross	7,581	7,581
Purchased software	'	'
Property, Plant and Equipment [Line Items]	'	'
Estimated useful lives	'3 years	'
Property and equipment, Gross	6,124	5,874
Furniture and fixtures	'	'
Property, Plant and Equipment [Line Items]	'	'
Estimated useful lives	'5 years	'
Property and equipment, Gross	1,656	1,582
Equipment	'	'
Property, Plant and Equipment [Line Items]	'	'
Estimated useful lives	'3 years	'
Property and equipment, Gross	$5,281	$4,876

Property_and_Equipment_Detail_

Property and Equipment (Detail Textuals) (USD $)	Sep. 30, 2013	Dec. 31, 2011
In Millions, except Per Share data, unless otherwise specified
Property, Plant and Equipment [Abstract]	'	'
Land and building sold into a sale-leaseback transaction	'	$12
Nominal price of termination agreement	$10	'

Property_and_Equipment_Detail_1

Property and Equipment (Detail Textuals 1) (USD $)	3 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Property, Plant and Equipment [Line Items]	'	'
Capitalized software development cost	$4,810,000	$2,856,000
Software Development	'	'
Property, Plant and Equipment [Line Items]	'	'
Intangible assets amortization method	'straight-line basis	'
Estimated economic life	'3 years	'
Capitalized software development cost	4,810,000	2,856,000
Amortization of capitalized software development costs	$1,447,000	$1,000,000

Acquisitions_Acquisition_of_as

Acquisitions- Acquisition of assets of GHN-Online, Inc. (Details) (USD $)	Sep. 30, 2013	Jun. 30, 2013	Dec. 31, 2012	Dec. 31, 2012	Dec. 31, 2012	Dec. 31, 2012	Dec. 31, 2012	Dec. 31, 2012	Dec. 31, 2012
In Thousands, unless otherwise specified			GHN-Online, Inc. (GHN)	GHN-Online, Inc. (GHN)	GHN-Online, Inc. (GHN)	GHN-Online, Inc. (GHN)	GHN-Online, Inc. (GHN)	GHN-Online, Inc. (GHN)	GHN-Online, Inc. (GHN)
				Property and Equipment	Developed Technology	Customer Relationships	Non-competition Agreements	Trademarks	Goodwill
Business Acquisition [Line Items]	'	'	'	'	'	'	'	'	'
Net Working Capital	'	'	$69	'	'	'	'	'	'
Property and Equipment	'	'	352	'	'	'	'	'	'
Developed Technology	'	'	2,437	'	'	'	'	'	'
Customer Relationships	'	'	1,054	'	'	'	'	'	'
Non-competition Agreements	'	'	211	'	'	'	'	'	'
Trademarks	'	'	277	'	'	'	'	'	'
Goodwill	1,540	1,540	1,100	'	'	'	'	'	'
Total fair value of consideration	'	'	$5,500	'	'	'	'	'	'
Estimated useful life	'	'	'	'3 years	'3 years	'9 years	'3-5 years	'10 years	'Indefinite

Acquisition_Detail_Textuals

Acquisition (Detail Textuals) (GHN-Online, Inc. (GHN), USD $)	1 Months Ended
	Dec. 31, 2012
GHN-Online, Inc. (GHN)	'
Business Acquisition [Line Items]	'
Business acquisition, cash consideration	$5,500,000
Business acquisition, transaction cost, total	$145,000

Transactions_with_Related_Part1

Transactions with Related Parties (Detail Textuals) (USD $)

Sep. 30, 2013

Jun. 30, 2013

Jul. 01, 2000

Sep. 30, 2013

Sep. 30, 2012

Mar. 31, 2002

Sep. 30, 2012

Mar. 31, 2002

Sep. 30, 2013

Jun. 30, 2013

Sep. 30, 2013

Jun. 30, 2013

Institutional_shareholder

Institutional_shareholder

Green Family Real Estate, LLC

Greenway Air, LLC

Greenway Air, LLC

Greenway Air, LLC

Greenway Air, LLC

Greenway Air, LLC

First Investor

First Investor

Second Investor

Second Investor

Other Assets

Other Assets

Related Party Transaction [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Agreement to lease the corporate office per month

'

'

$20,000

'

'

'

'

'

'

'

'

'

Aircraft hourly rental

'

'

'

0

18,000

'

'

'

'

'

'

'

Percentage equity interest acquired

'

'

'

'

15.75%

1.00%

'

'

'

'

'

'

Investment is recorded at cost

'

'

'

'

'

'

$427,000

$12,500

'

'

'

'

Number of institutional shareholders

2

2

'

'

'

'

'

'

'

'

'

'

Percentage of institutional shareholders collectively owned

44.00%

44.00%

'

'

'

'

'

'

25.00%

25.00%

19.00%

19.00%

Credit_Facility_Detail_Textual

Credit Facility (Detail Textuals) (USD $)	1 Months Ended	3 Months Ended		0 Months Ended
	Mar. 31, 2011	Sep. 30, 2013	Jun. 30, 2013	Aug. 16, 2013	Sep. 30, 2013	Jun. 30, 2013
	Line of Credit	Line of Credit	Line of Credit	Line of Credit	Letter of credit	Letter of credit
				New Loan Agreement
Line of Credit Facility [Line Items]	'	'	'	'	'	'
Current financing	$5,000,000	'	'	$25,000,000	'	'
Interest rate description	'LIBOR plus 275 basis points	'	'	'	'	'
Basis spread on variable rate	2.75%	'	'	'	'	'
Line of credit available	'	4,500,000	4,500,000	'	'	'
Letter of credit, amount	'	'	'	'	500,000	500,000
Term of credit facility	'	'	'	'4 years	'	'
Line of credit facility, paid off in full and canceled	'	$5,000,000	'	'	'	'

Shareholders_Equity_Details

Shareholders' Equity (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012
Cost of revenue:	'	'
Training and consulting services	$3,564	$4,602
Total cost of revenue	18,975	14,928
Operating expenses:	'	'
Sales, general and administrative	16,729	13,324
Research and development	4,535	4,772
Total operating expenses	21,264	18,096
Share-based Compensation	1,060	1,099
Stock Options	'	'
Cost of revenue:	'	'
System sales	8	8
Training and consulting services	51	47
Software support services	26	26
Electronic data interchange and business services	5	5
Total cost of revenue	90	86
Operating expenses:	'	'
Sales, general and administrative	800	843
Research and development	170	170
Total operating expenses	970	1,013
Share-based Compensation	$1,060	$1,099

Shareholders_Equity_Details_1

Shareholders' Equity (Details 1) (Stock Options, USD $)	3 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Risk-free interest rate	1.78%	'
Risk-free interest rate minimum	'	0.68%
Risk-free interest rate maximum	'	0.72%
Expected dividend yield	'	'
Expected volatility	55.90%	57.70%
Expected lives of options	'6 years 3 months	'6 years 3 months
Forfeiture rate	1.00%	1.00%
Fair Value	$8.75	'
Minimum	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Fair Value	'	8.24
Maximum	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Fair Value	'	8.62

Shareholders_Equity_Detail_Tex

Shareholders' Equity (Detail Textuals) (USD $)	3 Months Ended			3 Months Ended
In Millions, except Share data, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Dec. 16, 2011	Sep. 30, 2013	Sep. 30, 2012
	Stock Options	Stock Options	Stock Plan 2011	Stock Plan 2011	Stock Plan 2011
				Stock Options	Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'	'
Issuance of common stock awards authorized	'	'	3,000,000	'	'
Number of shares common stock granted	'	'	'	34,250	884,900
Number of options outstanding	3,700,000	4,000,000	'	'	'
Share based compensation expenses	$1.10	$1.10	'	'	'
Unrecognized compensation cost	$9.50	'	'	'	'
Expected recognition period for unrecognized compensation cost	'2 years	'	'	'	'

Income_Taxes_Detail_textuals

Income Taxes (Detail textuals) (USD $)	3 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Income Tax Disclosure [Abstract]	'	'
Net operating losses	$74,000,000	'
Research credit carryforwards	4,800,000	'
Valuation allowance attributable to the state R&D tax carryforwards	784,000	'
Effective rate	27.00%	46.00%
Operating loss before income tax	-6,610,000	15,000
Stock-based compensation expenses	$1,060,000	$1,099,000

Net_Income_Loss_Per_Share_Deta

Net Income (Loss) Per Share (Detail Textuals) (Stock Options)	3 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012
Stock Options	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Outstanding stock options exercisable for common shares (in shares)	1	1.3

Commitments_and_Contingencies_

Commitments and Contingencies (Detail Textuals) (USD $)	3 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Leases [Abstract]	'	'
Rental expenses recognized for building and equipment leases	$575,000	$407,000

Subsequent_Event_Detail_Textua

Subsequent Event (Detail Textuals) (Vista Equity Partners, USD $)	3 Months Ended
In Millions, except Per Share data, unless otherwise specified	Sep. 30, 2013	Nov. 04, 2013
	Sales, general and administrative expenses	Subsequent Event
Subsequent Event [Line Items]	'	'
Business acquisition tender offer outstanding shares, per share price	'	$20.35
Expenses related to acquisition	$1.80	'